Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 13826 - 13850 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:7843 female breast carcinoma HGNC:3689 Homo sapiens (human) 2263 FGFR2 mutant phenotype evidence used in manual assertion
  • PMID:31255687
DOID:9206 Barrett's esophagus RGD:620349 Rattus norvegicus (Norway rat) 29527 Ptgs2 mutant phenotype evidence used in manual assertion
  • PMID:17675820
DOID:12858 Huntington's disease HGNC:4851 Homo sapiens (human) 3064 HTT mutant phenotype evidence used in manual assertion
  • PMID:17940007
  • PMID:8898202
DOID:3525 middle cerebral artery infarction RGD:619991 Rattus norvegicus (Norway rat) 83785 Vegfa mutant phenotype evidence used in manual assertion
  • PMID:29497380
DOID:5419 schizophrenia RGD:3184 Rattus norvegicus (Norway rat) 24598 Nos1 mutant phenotype evidence used in manual assertion
  • PMID:20802999
DOID:9970 obesity HGNC:5471 Homo sapiens (human) 3485 IGFBP2 mutant phenotype evidence used in manual assertion
  • PMID:17259371
DOID:0080855 Parkinsonism HGNC:18618 Homo sapiens (human) 120892 LRRK2 mutant phenotype evidence used in manual assertion
  • PMID:20729864
DOID:2349 arteriosclerosis HGNC:7376 Homo sapiens (human) 4481 MSR1 mutant phenotype evidence used in manual assertion
  • PMID:14664792
DOID:11132 prostatic hypertrophy RGD:2581 Rattus norvegicus (Norway rat) 24890 Esr1 mutant phenotype evidence used in manual assertion
  • PMID:24872436
DOID:10763 hypertension RGD:3184 Rattus norvegicus (Norway rat) 24598 Nos1 mutant phenotype evidence used in manual assertion
  • PMID:20494920
DOID:2394 ovarian cancer HGNC:6190 Homo sapiens (human) 3716 JAK1 mutant phenotype evidence used in manual assertion
  • PMID:25319391
DOID:9256 colorectal cancer HGNC:18037 Homo sapiens (human) 196528 ARID2 mutant phenotype evidence used in manual assertion
  • PMID:33262464
DOID:13241 Behcet's disease HGNC:6006 Homo sapiens (human) 50615 IL21R mutant phenotype evidence used in manual assertion
  • PMID:21724243
DOID:9119 acute myeloid leukemia HGNC:15925 Homo sapiens (human) 25939 SAMHD1 mutant phenotype evidence used in manual assertion
  • PMID:30474474
DOID:1793 pancreatic cancer HGNC:9236 Homo sapiens (human) 5468 PPARG mutant phenotype evidence used in manual assertion
  • PMID:19152448
DOID:6432 pulmonary hypertension RGD:3714 Rattus norvegicus (Norway rat) 25553 Slc6a4 mutant phenotype evidence used in manual assertion
  • PMID:18074800
DOID:0050742 nicotine dependence WB:WBGene00000054 Caenorhabditis elegans 191602 acr-15 mutant phenotype evidence used in manual assertion
  • PMID:17081982
DOID:8947 diabetic retinopathy HGNC:3415 Homo sapiens (human) 2056 EPO mutant phenotype evidence used in manual assertion
  • PMID:24508793
DOID:1596 depressive disorder RGD:2056 Rattus norvegicus (Norway rat) 25083 Adra2a mutant phenotype evidence used in manual assertion
  • PMID:20047711
DOID:4450 renal cell carcinoma HGNC:8804 Homo sapiens (human) 5159 PDGFRB mutant phenotype evidence used in manual assertion
  • PMID:15994946
DOID:0060041 autism spectrum disorder HGNC:7176 Homo sapiens (human) 4318 MMP9 mutant phenotype evidence used in manual assertion
  • PMID:25466251
DOID:0060041 autism spectrum disorder WB:WBGene00003182 Caenorhabditis elegans 172732 mef-2 mutant phenotype evidence used in manual assertion
  • PMID:22859820
DOID:3355 fibrosarcoma HGNC:11916 Homo sapiens (human) 7132 TNFRSF1A mutant phenotype evidence used in manual assertion
  • PMID:10753499
DOID:224 transient cerebral ischemia HGNC:11179 Homo sapiens (human) 6647 SOD1 mutant phenotype evidence used in manual assertion
  • PMID:17110031
DOID:2018 hyperinsulinism RGD:3001 Rattus norvegicus (Norway rat) 24536 Lepr mutant phenotype evidence used in manual assertion
  • PMID:26537785
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025